期刊
JOURNAL OF INFECTIOUS DISEASES
卷 197, 期 5, 页码 693-697出版社
UNIV CHICAGO PRESS
DOI: 10.1086/527329
关键词
-
资金
- PHS HHS [T01/CCT622892] Funding Source: Medline
Candidate vaccine ChimeriVax viruses are attenuated, efficacious, safe, and highly unlikely to be transmitted by arthropod vectors. Nevertheless, concerns have been raised about the use of these vaccines because of the potential for recombination between vaccine and wild-type (WT) strains. To evaluate the vertebrate pathogenicity of such a worst-case recombinant, ChimeriVax-dengue (DEN) 4 virus was chimerized with the WT Asibi yellow fever virus. In this worst-case scenario, chimeric viruses remained fully attenuated in nonhuman primates. We therefore conclude that, even in the highly unlikely event of virulent backbone reversion, the safety of ChimeriVax-DEN vaccines would not be compromised.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据